Lifecycle management that integrates patents and pharmaceutical regulations, and future measures.
Our company will hold a business seminar. 【Practical Insights Gained from the Seminar】 - Criteria for determining the extension of the duration and the scope of extended patent effectiveness - Points to consider in patent practice based on clinical trials and regulatory submissions - Future strategies for pharmaceutical lifecycle management, including patent linkage 【Target Industries and Departments】 - Intellectual property and patent departments of pharmaceutical companies - Regulatory and research and development departments of pharmaceutical companies - Departments responsible for lifecycle management and business strategy of pharmaceuticals - Legal departments of pharmaceutical and biotech companies - Patent attorneys and lawyers specializing in pharmaceuticals and biotechnology 【Seminar Details】 ■ Date and Time: November 10, 2026 (Tuesday) 13:30 - 16:00 (Doors open at 13:00) ■ Venue: JPI Conference Square ■ Address: 5-2-32 Minamiazabu, Minato-ku, Tokyo, Kowa Hiroo Building ■ Participation Methods: In-person, live streaming, archived streaming ■ Instructor: Professor Hiroshi Kato, Nihon University Graduate School (Patent Attorney) *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Lecture Overview】 In recent years, the importance of lifecycle management (LCM strategy) that integrates patents and regulatory affairs has been increasing in pharmaceutical companies. In particular, following the Remicade OD tablet case in May of the 7th year of Reiwa, there have been a series of significant court cases regarding the extension of patent terms and the scope of extended patent rights, raising practical concerns. Additionally, there is a demand for addressing issues at the intersection of patents and regulatory affairs, such as patent linkage and clinical trials. In this lecture, we will explain patent strategies for extending patent terms based on the latest court cases and examination practices, as well as discuss future pharmaceutical LCM strategies and practical responses that integrate patents and regulatory affairs. 【Lecture Topics】 ■ Practical aspects of extending patent terms ■ Practical aspects of the scope of extended patent rights ■ Patent practices and regulatory applications based on clinical trials ■ Practical aspects of patent linkage and future directions ■ Future directions for pharmaceutical LCM strategies ■ Related Q&A ■ Business card exchange and networking (for in-person attendees only)
Price information
【Course Fee】 1 person: 37,470 yen (including tax) From 2 people onwards: 32,470 yen (including tax / same organization, simultaneous application) *For those affiliated with local public organizations, up to 2 people can register for 11,000 yen (including tax / venue and live streaming only, same participation format)
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
JPI Corporation (Japan Planning Institute) has been providing valuable information for executives and senior management involved in the execution of national policies and national projects, supporting the dissemination of state policies as a 'bridge of knowledge' between 'government', 'administration', and 'citizens' in the form of exclusive real seminars for participants for half a century, aiming to create national knowledge.
